CHARLENE REYES: Open Payments
NPI 1730331570 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 23 payments from 8 companies in 2025. Trend: 2023 $738 · 2024 $838 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Janssen Biotech, Inc. | 3 | $85 |
| Ardelyx, Inc. | 3 | $69 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: ENTYVIO, RINVOQ, TREMFYA, IBSRELA, Bard Urinary Drainage Bag, DUPIXENT, LINZESS, INJECTAFER.
Industry payments across VA — which companies pay providers there.
